Manpreet Bhalla

Manpreet Bhalla

Auto-generated profile, based on publicly available information

Manpreet Bhalla

National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Access Microbiology
Verified
Journal Article
Open access
AAAmit Aggarwal
Amit Aggarwal
MBManpreet Bhalla
Manpreet Bhalla
KFKhan Hena Fatima
Khan Hena Fatima
Background. Organisms possessing the bla NDM-1 gene (responsible for carbapenem resistance) with a class-1 integron can acquire many other antibiotic resistance genes from the community sewage pool and become multidrug-resistant superbugs. In this regard, hospital sewage, which contains a large quantity of residual antibiotics, metals and disinfectants, is being recognized as a significant cause of antimicrobial resistance (AMR) origination and spread across the major centres of the world and is thus routinely investigated as a marker for tracing the origin of drug resistance. Therefore, in this study, an attempt has been made to identify and characterize the carbapenem-resistant microbes associated with integron genes amongst the organisms isolated from the effluent treatment plant (ETP) installed in a tertiary respiratory care hospital in Delhi, India. Methods. One hundred and thirty-eight organisms belonging to Escherichia , Klebsiella , Pseudomonas and Acinetobacter spp. were collected from the incoming and outgoing sewage lines of the ETP. Carbapenem sensitivity and characterization was performed by the imipenem and imipenem-EDTA disc diffusion method. Later DNA extraction and PCR steps were performed for the Int-1 and bla NDM-1 genes. Results. Of the 138 organisms, 86 (62.3 %) were imipenem-resistant (P<0.05). One hundred and twenty-four (89.9 %) organisms had one or both of the genes. Overall, the bla NDM-1 gene (genotypic resistance) was present in 71 % (98/138) of organisms. 53.6 % (74/138) organisms were double gene-positive (bla NDM-1 + Int-1), of which 40 were producing the metallo-beta-lactamase enzyme, making up almost 28.9 % (40/138) of the collected organisms. Conclusion. The current study strengthens the hypothesis that Carbapenem resistant organisms are in a high-circulation burden through the human gut and hospital ETPs are providing an environment for resistance origination and amplification.

15 May 2025 in Journal of Infection
Verified
Journal Article
Open access
BDBella Devaleenal Daniel
Bella Devaleenal Daniel
SSSivakumar Shanmugam
Sivakumar Shanmugam
RMRashi Mehta
Rashi Mehta
MBManpreet Bhalla
Manpreet Bhalla
MMMuthuvijayalakshmi Mariappan
Muthuvijayalakshmi Mariappan
CPChandrasekaran Padmapriyadarsini
Chandrasekaran Padmapriyadarsini
Assess the effectiveness of bedaquiline, pretomanid and linezolid (BPaL) regimens with varying doses and duration of linezolid at the end of 48 weeks post treatment among drug resistant tuberculosis (DR TB) patients. Multicentric pragmatic randomized clinical trial in which BPaL regimens were given for 26 weeks for pulmonary pre extensively drug resistant tuberculosis (PreXDR TB); bedaquiline, pretomanid and linezolid 600 mg for 26 weeks (arm1), structured dose reduction arms with linezolid dose reduction from 600 to 300 mg after nine weeks (arm2) and 13 weeks (arm3). Participants were followed up for recurrence-free cure up to 48 weeks post-treatment. Whole genome sequencing in sputum samples at baseline and recurrence differentiated relapse and reinfection. Of 403 enrolled, 378 were included for the modified intent-to-treat analysis based on baseline sputum culture positivity and sensitivity to medications in the study regimen. Among them, 331(88%) had recurrence-free cure at the end of 48 weeks of post-treatment follow-up; arm1:112(87%), arm2:110(88%), arm3:109(88%). Overall, 14 (12 bacteriological and 2 clinical) recurrences (arm1-four, 2-six and 3-four) occurred; 11 recurrences occurred within 24 weeks after treatment completion; four out of 11 within the first 12 weeks. Of the 10 paired sputum samples available at baseline and recurrence for comparison of lineages, there were two reinfections and eight relapses. Structured dose reduction arms had comparable recurrence free cure rates as linezolid 600 mg arm when given along with bedaquiline and pretomanid for 26 weeks in PreXDR TB. Most of the recurrences occurred within the first six months.

1 September 2013 in Immunology and Infectious Diseases
Verified
Journal Article
Open access
PDF file
MSMradula Singh
Mradula Singh
PSParas Singh
Paras Singh
VMVithal Prasad Myneedu
Vithal Prasad Myneedu
MBManpreet Bhalla
Manpreet Bhalla
PAPuncham Adlakha
Puncham Adlakha
RSRohit Sarin
Rohit Sarin
Background & Objectives: Globally, tuberculosis (TB) still remains a major public health problem. India is a high TB burden country contributing to 26 per cent of global TB burden. Pulmonary tuberculosis (PTB) cases are more common (~ 90% of cases) while extra pulmonary tuberculosis (EPTB) constitutes around 10 to 20% of all tuberculosis cases in India. The diagnosis of the EPTB cases is difficult because of few bacilli and consequently is associated with low sensitivity of Zhiel-Neelson (ZN) smear and culture on LJ media. The present study evaluates the utility of PCR for the detection of M. tuberculosis in paucibacillary extra pulmonary and pulmonary tuberculosis samples. Methods: A total of 561 samples (553 EPTB & 8 PTB cases) were collected from the extra pulmonary and pulmonary tuberculosis patients which were processed for ZN smear, culture on LJ media and conventional PCR using two gene targets (IS6110 and MPB64). Results: The PCR positivity of IS6110 and MPB64 gene targets was found to be 91.3% (N=63/69) and 89.9% (N= 62/69) in majority of smear negative & culture positive (as a gold standard) extra pulmonary cases, respectively. However the PCR positivity was observed 100% in smear positive, culture positive Line probe assay tested MDR PTB cases (true positive controls; N=34). Further the PCR specificity was determined >95% (true negative healthy controls; N=26). The positivity of M. tuberculosis by IS6110 & MPB 64 gene targets was found to be range of 88% to 100% in various clinical paucibacillary extra pulmonary samples i.e. pleural fluid, ascitic fluid, lymph node, pus, CSF and others. Our data on 64 samples (non respiratory, n=63 & respiratory samples, n=1) revealed 40.6% positivity by Cobas TaqMan Real Time PCR (utilizing 16S rRNA probe; Roche, USA). Interpretation & Conclusion: Our data revealed that utility of both PCR and Real Time PCR in rapid diagnosis of M. tuberculosis in paucibacillary extra pulmonary tuberculosis samples in Indian scenario.

17 February 2022 in Current Microbiology
Verified
Journal Article
Closed access
PDF file
DADivya Anthwal
Divya Anthwal
SJShaina Jamwal
Shaina Jamwal
RGRakesh Kumar Gupta
Rakesh Kumar Gupta
RSRitu Singhal
Ritu Singhal
AVAjoy Verma
Ajoy Verma
SHSagarika Haldar
Sagarika Haldar